A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To attempt to demonstrate the efficacy of ganciclovir (DHPG) treatment of cytomegalovirus
(CMV) colitis in AIDS patients by evaluating both clinical and virologic parameters. To
determine acceptability and the safety profile of a 2-week course of intravenous (IV) DHPG
therapy.